POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether the drug dasatinib could help control several rare blood disorders including leukemia, myelofibrosis, and mastocytosis. Participants took dasatinib pills daily for as long as it helped control their disease. Researchers monitored blood counts and bone ma…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for tough blood cancer cases
Disease control CompletedThis study tested a drug called itacitinib for people with a serious bone marrow cancer called myelofibrosis who had already tried other standard treatments. The main goals were to find a safe dose and see if the drug could reduce spleen size and improve symptoms. Only four peopl…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Scientists test new combo against aggressive blood cancers
Disease control CompletedThis study tested a combination of two drugs, ruxolitinib and CPX-351, for patients with advanced forms of certain blood cancers that had worsened. The main goals were to find the safest dose of the combination and to see how well it worked to control the cancer. The trial involv…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC
-
Gentler transplant strategy tested for tough blood cancers
Disease control CompletedThis study tested a two-step, lower-intensity stem cell transplant for patients with high-risk blood cancers like leukemia and lymphoma. The goal was to use milder chemotherapy and radiation before the transplant to reduce side effects while still allowing the donor's immune cell…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC